Versant Venture Capital III, L.P. insider trades: Flexion Therapeutics (FLXN) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Versant Venture Capital III, L.P. reports to the SEC
and 1 more company
Open-market buys and sales
16 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 8, 2016 | FLXN | ↑ Buy | 714,285 | $14.00 | $10.0M | Indirect | Jun 10, 2016 (2d) |
| May 23, 2016 | PZRX | ↑ Buy | 596,477 | $5.00 | $3.0M | By Versant Venture Capital III, L.P. | May 24, 2016 (1d) |
| May 23, 2016 | PZRX | ↑ Buy | 3,523 | $5.00 | $18K | By Versant Side Fund III, L.P. | May 24, 2016 (1d) |
| May 23, 2016 | PZRX | ↓ Sell | 256,529 | $0.01 | $3K | By Versant Venture Capital III, L.P. | May 24, 2016 (1d) |
| May 23, 2016 | PZRX | ↓ Sell | 1,515 | $0.01 | $15 | By Versant Side Fund III, L.P. | May 24, 2016 (1d) |
| Jun 15, 2015 | OCUL | ↓ Sell | 318,122 | $22.00 | $7.0M | Direct | Jun 15, 2015 (0d) |
| Jun 15, 2015 | OCUL | ↓ Sell | 1,878 | $22.00 | $41K | Indirect | Jun 15, 2015 (0d) |
| Jun 10, 2015 | OCUL | ↓ Sell | 424,494 | $22.00 | $9.3M | Direct | Jun 11, 2015 (1d) |
| Jun 10, 2015 | OCUL | ↓ Sell | 2,506 | $22.00 | $55K | Indirect | Jun 11, 2015 (1d) |
| May 8, 2015 | OPGN | ↑ Buy | 410,906 | $6.00 | $2.5M | By Versant Venture Capital III, L.P. | May 12, 2015 (4d) |
| May 8, 2015 | OPGN | ↑ Buy | 2,426 | $6.00 | $15K | By Versant Side Fund III, L.P. | May 12, 2015 (4d) |
| Jul 29, 2014 | IMDZ | ↑ Buy | 233,333 | $12.00 | $2.8M | Direct | Jul 31, 2014 (2d) |
| Jul 29, 2014 | IMDZ | ↓ Sell | 208,334 | $12.00 | $2.5M | Direct | Jul 31, 2014 (2d) |
| Feb 18, 2014 | FLXN | ↑ Buy | 305,886 | $13.00 | $4.0M | Direct | Feb 20, 2014 (2d) |
| Feb 18, 2014 | FLXN | ↑ Buy | 1,806 | $13.00 | $23K | By Versant Side Fund III, L.P. | Feb 20, 2014 (2d) |
| Aug 6, 2010 | TSRX | ↑ Buy | 914,529 | $5.00 | $4.6M | Indirect | Aug 10, 2010 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Versant Venture Capital III, L.P.'s insider trades
Versant Venture Capital III, L.P. is a 10% owner of Flexion Therapeutics (FLXN). Since Aug 6, 2010, it has reported 9 open-market purchases worth $26.9M and 7 sales worth $18.9M on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include conversions (6 filings), option exercises (3 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every FLXN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.